Investorideas.com - New Brunswick becomes first province in Canada to fully secure safe supply of cannabis for all its consumers
Monday, November 20, 2017
Investorideas.com - Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto Rico to Begin Human Trials of Its Lead #Cannabis Strain for Pain
Investorideas.com - Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto Rico to Begin Human Trials of Its Lead #Cannabis Strain for Pain
Veritas
Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:
2VP), (“Veritas” or the “Company”) announces that its research arm, Cannevert
Therapeutics Ltd. ("CTL") has signed a letter of intent with the
Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first
human study of CTL-X, its lead cannabis strain targeting pain.
Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:
2VP), (“Veritas” or the “Company”) announces that its research arm, Cannevert
Therapeutics Ltd. ("CTL") has signed a letter of intent with the
Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first
human study of CTL-X, its lead cannabis strain targeting pain.
The
study will be done in two stages to assess the analgesic effects of this lead
strain. The first stage will have an open label design to look at the feasibility
of two doses of CTL-X in 5 subjects while the second stage will use a
randomized, double-blind, crossover design to assess one dose of CTL-X against
a placebo control strain in 16 subjects who will be exposed to various
modalities of acute pain.
study will be done in two stages to assess the analgesic effects of this lead
strain. The first stage will have an open label design to look at the feasibility
of two doses of CTL-X in 5 subjects while the second stage will use a
randomized, double-blind, crossover design to assess one dose of CTL-X against
a placebo control strain in 16 subjects who will be exposed to various
modalities of acute pain.
Friday, November 17, 2017
Investorideas.com - ParcelPal (OTC: $PTNYF) (CSE: $PKG.CN) (FSE: $PT0) Expands Restaurant Offerings on Platform
Investorideas.com - ParcelPal (OTC: $PTNYF) (CSE: $PKG.CN) (FSE: $PT0) Expands Restaurant Offerings on Platform
ParcelPal is a technology driven
logistics company that connects consumers to the goods they love. Customers can
shop at partner businesses and through the ParcelPal technology receive their
purchased goods within an hour. The Company offers on-demand delivery of
merchandise from leading retailers, restaurants, medical marijuana dispensaries
and liquor stores in Vancouver and soon in major cities Canada-wide.
logistics company that connects consumers to the goods they love. Customers can
shop at partner businesses and through the ParcelPal technology receive their
purchased goods within an hour. The Company offers on-demand delivery of
merchandise from leading retailers, restaurants, medical marijuana dispensaries
and liquor stores in Vancouver and soon in major cities Canada-wide.
Thursday, November 16, 2017
Investorideas.com - Today's Viridian #Cannabis Deal Tracker for Week Ended November 10, 2017
Investorideas.com - Today's Viridian #Cannabis Deal Tracker for Week Ended November 10, 2017
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - The Lowdown On Getting High In Canada
Investorideas.com - The Lowdown On Getting High In Canada
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)